Biotechnology And Bioengineering Are Coming To The Forefront

Biotechnology and bioengineering are sciences which may have the opportunity to alter the manner in which basic industries such as agriculture are carried out arround the world, and to achieve this in the most dramatic way. It is possible to create new strains of crops which could have far higher average yields, as a result of a higher resistance against disease and even against naturally occurring weather conditions. The science of biotechnology has reached the stage where it's turning theories into realities, which can result in major benefits for the entire population of the planet.

These industries have inevitably taken time for them to make it to the point they're at today. There is a natural progression which can be observed in the growth of industries and new technologies throughout history. A new development will start off extremely slowly, with only a handful of visionaries able to carry out experiments which will take the science forward. When the first successful advances are made, momentum begins to pick up. It is at the point when the science can be applied commercially that it really begins to take off, as financial backers will now see the chance of a significant profit over time.

This stage has been passed through the use of biotechnology in agriculture. There are crops which have been produced to allow food to remain fresher for a longer period of time, and also crops which are resistant against disease. This greatly affects the consumption of staple food items such as rice and bread. In Africa, for instance, there is regular wastage of the rice crop and a significant danger of famine which biotechnology can eliminate. In the West, large quantities of bread are thrown away when they become inedible, and the technology for growing longer lasting bread is already here.


The application of biotechnology and bioengineering in pharmaceutical development isn't very well advanced, however the possibility for future profit is assured. Many drugs are needed in huge quantities to satisfy the demands of people who need to use them regularly, and drug production can be increased through biotechnology. A classic case is insulin, which can be produced from a variety of sources and which is easily absorbed by the body in any case. It is possible to produce far higher quantities of insulin at a cheaper price using biotechnology, and the benefit to diabetics worldwide will be enormous.

It's to generally be admitted there presently exists controversial aspects to bioengineering especially, and therefore many intelligent individuals are concerned about the potential misuse of the technology. We have now passed the point where it is possible to clone an animal from a pre-existing specimen, and this inevitably brings us to the question of whether human beings may one day be cloned. There are obviously horrifying implications to this possibility, although the ability to clone replacement limbs or organs for a human being could be a highly positive step and could eliminate unnecessary transplants.


No matter what the future of biotechnology and bioengineering might be, you can be certain that they'll play a substantial role in the economic development of the West for quite some time to come. There are many difficult problems within out society which can potentially be solved by the use of these technologies, and it can happen in a way which will have knock on benefits throughout the entire world. If you are looking for sector in which to invest your money with an excellent chance of high reward, then this is a sector to look at closely. As long as you cover your risk with investments which have greater safety, you can benefit from investing in biotechnology and bioengineering.

Richard Tipsword





Biotech News:


Big Week of Earnings for Big Biotech ETF
Last week, Federal Reserve Chief Janet Yellen dealt a blow to the biotechnology sector when, in a rare move for any Fed chair, she said valuations for smaller biotech firms EURœappear substantially stretched.EUR ...

Puma Biotech's Breast Cancer Drug Results Mint New Billionaire Overnight
Puma Biotech announced on Tuesday that a Phase III clinical trial of its experimental drug blocked the return of breast cancer in some women. Shares of the small development biotech firm more than tripled on Wednesday morning after the news -- and created a new billionaire in the process...

La. Tech professor to present at International Bioprinting Congress in Singapore - Shreveport Times

Science Codex

La. Tech professor to present at International Bioprinting Congress in Singapore
Shreveport Times
RUSTON EUR Mark DeCoster, the James E. Wyche III Endowed Professor in Biomedical Engineering at Louisiana Tech University, will present as an invited speaker at the International Bioprinting Congress, July 24-25 at the Biopolis Research and Development .
Louisiana Tech University professor presents at International Bioprinting CongressPhys.Org

all 6 news articles »

Health Canada Approves DispersinB(R) for Human Use
Kane Biotech Inc. , a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, is pleased to announce it has obtained Health Canada's ...